Table 1 Baseline variables and non-alcoholic fatty liver disease (NAFLD) status at the end of follow-up according to the tertiles of nonHDLc/HDL ratio (n = 2717)
Variable | nonHDLc/HDL ratio | P value | ||
|---|---|---|---|---|
Tertile 1 | Tertile 2 | Tertile 3 | ||
(0.44–1.65; n = 906) | (1.66–2.36; n = 905) | (2.37–6.05; n = 906) | ||
Age (yr) | 38.83 ± 12.16 | 40.97 ± 12.19 | 42.11 ± 11.41 | < 0.001 |
Sex, n (%) | < 0.001 | |||
Female | 556 (61.37) | 458 (50.61) | 315 (34.77) | |
Male | 350 (38.63) | 447 (49.39) | 591 (65.23) | |
Body mass index (kg/m2) | 21.12 ± 2.36 | 22.25 ± 2.57 | 23.47 ± 2.51 | < 0.001 |
Hypertension, n (%) | 64 (7.48) | 103 (12.06) | 142 (16.49) | < 0.001 |
Systolic BP (mmHg) | 109.64 ± 13.33 | 112.55 ± 13.99 | 115.80 ± 14.79 | < 0.001 |
Diastolic BP (mmHg) | 73.11 ± 8.55 | 75.09 ± 8.88 | 77.80 ± 9.59 | < 0.001 |
Fasting plasma glucose (mmol/l) | 4.77 ± 0.42 | 4.88 ± 0.48 | 4.90 ± 0.51 | < 0.001 |
Triglycerides (mmol/l) | 0.83 (0.4) | 1.04 (0.59) | 1.55 (1) | < 0.001 |
Total cholesterol (mmol/l) | 4.26 ± 0.68 | 4.67 ± 0.67 | 5.01 ± 0.79 | < 0.001 |
LDLc (mmol/l) | 1.99 ± 0.46 | 2.49 ± 0.49 | 2.88 ± 0.66 | < 0.001 |
HDLc (mmol/l) | 1.85 ± 0.30 | 1.56 ± 0.24 | 1.27 ± 0.22 | < 0.001 |
ALT (U/L) | 17.54 ± 9.33 | 20.19 ± 10.94 | 23.79 ± 11.81 | < 0.001 |
AST (U/L) | 20.49 ± 6.32 | 20.97 ± 6.41 | 21.81 ± 6.82 | < 0.001 |
Incident NAFLD, n (%) | 31 (3.42) | 61 (6.74) | 172 (18.98) | < 0.001 |